View in EDS

PRS46 - Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden.

Saved in:

Bibliographic Details
Title:	PRS46 - Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden.
Authors:	Wlodarczyk, J¹, Hunsche, E², Silberberg, B¹, Kemp, D¹, Anell, B³, Corcoran, K³, Minacori, R⁴, Stevenson, M⁵, Beaudet, A²
Source:	Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA556-A556. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	10983015
DOI:	10.1016/j.jval.2016.09.1214